[ XXXX following intravesical BCG-therapy].

@entity1 @entity353 @entity288 @entity281 @entity150 @entity358 @entity751 @entity221 @entity1907
A @entity1 given intravesical BCG immunotherapy developed @entity1907 . After resection of a superficial @entity150 , the @entity1 was given weekly intravesical BCG infusions. After the 4th session, the @entity1 developed @entity221 (40 degrees C), shivers, dry cough, profuse sweating, and @entity353 . Initially, the chest x-ray was normal. The @entity1 was given isoniazid (5 mg/kg) in a single-drug regimen. Rapid degradation of the general status led to a new chest x-ray, 10 days later, which demonstrated a @entity751 . High-resolution thoracic CT confirmed the diagnosis of @entity1907 . A three-drug antituberculosis regimen associated with @entity288 was followed by restoration of the general status. Antituberculosis therapy was continued for 9 months. The 9-month thoracic CT revealed a smaller number of micronodules in the @entity358 . This case illustrates the discussion concerning the appropriate treatment for @entity1 who develop a @entity281 after intravesical BCG-therapy.
